Dong W, Li S, Tang W, Sun Q, Zhu P, Wang M
Sci Rep. 2025; 15(1):5371.
PMID: 39948137
PMC: 11825652.
DOI: 10.1038/s41598-025-89521-z.
Gao F, Gong W, He H, Zhang Z, Yang H, Shao F
Cancer Immunol Immunother. 2024; 74(1):38.
PMID: 39738645
PMC: 11685357.
DOI: 10.1007/s00262-024-03870-8.
Yang X, Chatterjee D, Couetil J, Liu Z, Ardon V, Chen C
Front Genet. 2024; 15:1410353.
PMID: 39678375
PMC: 11638177.
DOI: 10.3389/fgene.2024.1410353.
Zaman S, Pagare P, Ma H, Hoyle R, Zhang Y, Li J
RSC Med Chem. 2024; .
PMID: 39281802
PMC: 11393732.
DOI: 10.1039/d4md00122b.
Tamada H, Uehara T, Yoshizawa T, Iwaya M, Asaka S, Nakajima T
Diagn Pathol. 2024; 19(1):116.
PMID: 39198902
PMC: 11350935.
DOI: 10.1186/s13000-024-01537-7.
Discovery and validation of a 10-gene predictive signature for response to adjuvant chemotherapy in stage II and III colon cancer.
Xu C, Xia P, Li J, Lewis K, Ciombor K, Wang L
Cell Rep Med. 2024; 5(8):101661.
PMID: 39059386
PMC: 11384724.
DOI: 10.1016/j.xcrm.2024.101661.
Integration of single-cell sequencing and bulk RNA-seq to identify and develop a prognostic signature related to colorectal cancer stem cells.
Wu J, Li W, Su J, Zheng J, Liang Y, Lin J
Sci Rep. 2024; 14(1):12270.
PMID: 38806611
PMC: 11133358.
DOI: 10.1038/s41598-024-62913-3.
Leucine-rich repeat-containing G protein-coupled receptor 5 expression in lymph node metastases of colorectal cancer: Clinicopathological insights and prognostic implications.
Sawaguchi H, Uehara T, Iwaya M, Asaka S, Nakajima T, Kamakura M
Pathol Int. 2024; 74(7):387-393.
PMID: 38787285
PMC: 11551821.
DOI: 10.1111/pin.13439.
Association of the TRIM family protein with survival outcomes and clinicopathological features in colorectal cancer: a systematic review and meta-analysis.
Wu Y, Chen C, Hua X, Zhao C, Min H
BMC Cancer. 2024; 24(1):537.
PMID: 38678238
PMC: 11055242.
DOI: 10.1186/s12885-024-12280-z.
Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases.
Bootsma S, Dings M, Kesselaar J, Helderman R, van Megesen K, Constantinides A
Cell Rep Med. 2024; 5(5):101523.
PMID: 38670098
PMC: 11148637.
DOI: 10.1016/j.xcrm.2024.101523.
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer.
Hoover E, Ruggiero O, Swingler R, Day E
ACS Omega. 2024; 9(12):14323-14335.
PMID: 38559981
PMC: 10976388.
DOI: 10.1021/acsomega.3c10275.
Achaete-scute family bHLH transcription factor 2 activation promotes hepatoblastoma progression.
Kato Y, Fukazawa T, Tanimoto K, Kanawa M, Kojima M, Saeki I
Cancer Sci. 2024; 115(3):847-858.
PMID: 38183173
PMC: 10921009.
DOI: 10.1111/cas.16051.
KRAS allelic imbalance drives tumour initiation yet suppresses metastasis in colorectal cancer in vivo.
Najumudeen A, Fey S, Millett L, Ford C, Gilroy K, Gunduz N
Nat Commun. 2024; 15(1):100.
PMID: 38168062
PMC: 10762264.
DOI: 10.1038/s41467-023-44342-4.
Single-cell deconvolution reveals high lineage- and location-dependent heterogeneity in mesenchymal multivisceral stage 4 colorectal cancer.
Berlin C, Mauerer B, Cauchy P, Luenstedt J, Sankowski R, Marx L
J Clin Invest. 2023; 134(5).
PMID: 38153787
PMC: 10904044.
DOI: 10.1172/JCI169576.
TIM-3 Expression and M2 Polarization of Macrophages in the TGFβ-Activated Tumor Microenvironment in Colorectal Cancer.
Katagata M, Okayama H, Nakajima S, Saito K, Sato T, Sakuma M
Cancers (Basel). 2023; 15(20).
PMID: 37894310
PMC: 10605063.
DOI: 10.3390/cancers15204943.
Advances in immunotyping of colorectal cancer.
Wu Y, Zhuang J, Qu Z, Yang X, Han S
Front Immunol. 2023; 14:1259461.
PMID: 37876934
PMC: 10590894.
DOI: 10.3389/fimmu.2023.1259461.
Grp78 is required for intestinal Kras-dependent glycolysis proliferation and adenomagenesis.
Spaan C, de Boer R, Smit W, van der Meer J, van Roest M, Vermeulen J
Life Sci Alliance. 2023; 6(11).
PMID: 37643866
PMC: 10465924.
DOI: 10.26508/lsa.202301912.
Less demand on stem cell marker-positive cancer cells may characterize metastasis of colon cancer.
Kaida T, Fujiyama Y, Soeno T, Yokota M, Nakamoto S, Goto T
PLoS One. 2023; 18(4):e0277395.
PMID: 37098074
PMC: 10128954.
DOI: 10.1371/journal.pone.0277395.
Lower Expression of Is Associated with Higher Mortality in a Meta-Analysis of Individuals with Colorectal Cancer.
Scott P, Wang S, Onyeaghala G, Pankratz N, Starr T, Prizment A
Cancers (Basel). 2023; 15(3).
PMID: 36765944
PMC: 9913301.
DOI: 10.3390/cancers15030989.
The Cancer-Associated Fibroblasts-Related Gene COMP Is a Novel Predictor for Prognosis and Immunotherapy Efficacy and Is Correlated with M2 Macrophage Infiltration in Colon Cancer.
Ma H, Qiu Q, Tan D, Chen Q, Liu Y, Chen B
Biomolecules. 2023; 13(1).
PMID: 36671447
PMC: 9856124.
DOI: 10.3390/biom13010062.